FDA NDC Directory · JSON-LD · Markdown

Etoposide

NDC 68001-265 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA074513
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsETOPOSIDE (20 mg/mL)
Marketing started20131114
Package count3

External sources

Source: openFDA. Public-domain (CC0).